share_log

港股公告掘金 | 艾美疫苗:第二代高效价吸附破伤风疫苗获得临床试验许可

Hong Kong Stock Announcement Gold Digging | Aimei Vaccine: The second generation of highly effective adsorbed tetanus vaccine has obtained clinical trial approval.

Zhitong Finance ·  Dec 19, 2024 16:03

CHINESE EST H (00127) subsidiary plans to sell London property in the United Kingdom for 0.162 billion British Pounds. Lion King Holdings (02562) plans to jointly hold a reality show project "SuperStreamer Asia" with a Singaporean artist management media company and others.

[Significant Events]

CHINESE EST H (00127) subsidiary plans to sell London property in the United Kingdom for 0.162 billion British Pounds.

Lion King Holdings (02562) plans to jointly hold a reality show project "SuperStreamer Asia" with Singapore's artist management media company and others.

Aimee Vaccine (06660): The second generation high-efficiency adsorbed tetanus vaccine has received clinical trial approval.

Aimei Vaccine (06660): New technological route for suspended culture of quadrivalent MDCK cell influenza vaccine has obtained clinical trial approval.

Future Data Group (08229) has established multiple strategic collaborations for the development of the low-altitude economy Business.

Lianlian Digital (02598) obtained a license for operating a virtual asset trading platform in Hong Kong.

PENTAMASTER (01665) is privatized at a premium and will resume trading on December 20.

HENLIUS (02696): A cooperation and licensing agreement has been established with PALLEON regarding E-602 and combination therapy.

[Earnings Reports Data]

S.F. Holding (06936) reported a total revenue of 25.196 billion yuan in November from the express logistics, supply chain, and international business, marking a year-on-year growth of 6.73%.

AEON CREDIT (00900) announced its performance for the first nine months, with a net profit of approximately 0.275 billion Hong Kong dollars, a year-on-year decrease of 2.46%.

IRC (01029): In the third quarter, produced 0.609 million tons of iron concentrate, a quarter-on-quarter increase of 1.3%.

For more details, please refer to 智通财经网().

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment